Global Autoimmune Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Autoimmune Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Autoimmune Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Rheumatoid Arthritis (RA)
1.2.3 Multiple Sclerosis (MS)
1.2.4 Psoriasis
1.2.5 Inflammatory Bowel Disease (IBD)
1.2.6 Ankylosing Spondylitis (AS)
1.2.7 Systemic Lupus Erythematosus (SLE)
1.3 Market Segment by Application
1.3.1 Global Autoimmune Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Autoimmune Drugs Market Size (2017-2028)
2.1.1 Global Autoimmune Drugs Revenue (2017-2028)
2.1.2 Global Autoimmune Drugs Sales (2017-2028)
2.2 Global Autoimmune Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Autoimmune Drugs Sales by Regions (2017-2022)
2.2.2 Global Autoimmune Drugs Revenue by Regions (2017-2022)
2.3 Global Autoimmune Drugs Market Size Forecast by Region
2.3.1 Global Autoimmune Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Autoimmune Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Autoimmune Drugs Regions (Countries) Ranking by Market Size
2.5 Autoimmune Drugs Market Dynamics
2.5.1 Autoimmune Drugs Market Trends
2.5.2 Autoimmune Drugs Market Drivers
2.5.3 Autoimmune Drugs Market Challenges
2.5.4 Autoimmune Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Autoimmune Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Autoimmune Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Autoimmune Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Autoimmune Drugs Sales in 2021
3.2 Global Top Manufacturers Autoimmune Drugs by Revenue
3.2.1 Global Autoimmune Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Autoimmune Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Autoimmune Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Drugs as of 2021)
3.4 Global Autoimmune Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Autoimmune Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Autoimmune Drugs Market
3.7 Key Manufacturers Autoimmune Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Autoimmune Drugs Market Size by Type
4.1 Global Autoimmune Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Autoimmune Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Autoimmune Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Autoimmune Drugs Price by Type (2017-2022)
4.2 Global Autoimmune Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Autoimmune Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Autoimmune Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Autoimmune Drugs Price Forecast by Type (2023-2028)
5 Global Autoimmune Drugs Market Size by Application
5.1 Global Autoimmune Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Autoimmune Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Autoimmune Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Autoimmune Drugs Price by Application (2017-2022)
5.2 Global Autoimmune Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Autoimmune Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Autoimmune Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Autoimmune Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Autoimmune Drugs Sales Breakdown by Company
6.1.1 North America Autoimmune Drugs Sales by Company (2017-2022)
6.1.2 North America Autoimmune Drugs Revenue by Company (2017-2022)
6.2 North America Autoimmune Drugs Market Size by Type
6.2.1 North America Autoimmune Drugs Sales by Type (2017-2028)
6.2.2 North America Autoimmune Drugs Revenue by Type (2017-2028)
6.3 North America Autoimmune Drugs Market Size by Application
6.3.1 North America Autoimmune Drugs Sales by Application (2017-2028)
6.3.2 North America Autoimmune Drugs Revenue by Application (2017-2028)
6.4 North America Autoimmune Drugs Market Size by Country
6.4.1 North America Autoimmune Drugs Sales by Country (2017-2028)
6.4.2 North America Autoimmune Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Autoimmune Drugs Sales Breakdown by Company
7.1.1 Europe Autoimmune Drugs Sales by Company (2017-2022)
7.1.2 Europe Autoimmune Drugs Revenue by Company (2017-2022)
7.2 Europe Autoimmune Drugs Market Size by Type
7.2.1 Europe Autoimmune Drugs Sales by Type (2017-2028)
7.2.2 Europe Autoimmune Drugs Revenue by Type (2017-2028)
7.3 Europe Autoimmune Drugs Market Size by Application
7.3.1 Europe Autoimmune Drugs Sales by Application (2017-2028)
7.3.2 Europe Autoimmune Drugs Revenue by Application (2017-2028)
7.4 Europe Autoimmune Drugs Market Size by Country
7.4.1 Europe Autoimmune Drugs Sales by Country (2017-2028)
7.4.2 Europe Autoimmune Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Autoimmune Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Autoimmune Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Autoimmune Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Autoimmune Drugs Market Size by Type
8.2.1 Asia Pacific Autoimmune Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Autoimmune Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Autoimmune Drugs Market Size by Application
8.3.1 Asia Pacific Autoimmune Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific Autoimmune Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Autoimmune Drugs Market Size by Region
8.4.1 Asia Pacific Autoimmune Drugs Sales by Region
8.4.2 Asia Pacific Autoimmune Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Autoimmune Drugs Sales Breakdown by Company
9.1.1 Latin America Autoimmune Drugs Sales by Company (2017-2022)
9.1.2 Latin America Autoimmune Drugs Revenue by Company (2017-2022)
9.2 Latin America Autoimmune Drugs Market Size by Type
9.2.1 Latin America Autoimmune Drugs Sales by Type (2017-2028)
9.2.2 Latin America Autoimmune Drugs Revenue by Type (2017-2028)
9.3 Latin America Autoimmune Drugs Market Size by Application
9.3.1 Latin America Autoimmune Drugs Sales by Application (2017-2028)
9.3.2 Latin America Autoimmune Drugs Revenue by Application (2017-2028)
9.4 Latin America Autoimmune Drugs Market Size by Country
9.4.1 Latin America Autoimmune Drugs Sales by Country (2017-2028)
9.4.2 Latin America Autoimmune Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Autoimmune Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Autoimmune Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Autoimmune Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Autoimmune Drugs Market Size by Type
10.2.1 Middle East and Africa Autoimmune Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Autoimmune Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Autoimmune Drugs Market Size by Application
10.3.1 Middle East and Africa Autoimmune Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa Autoimmune Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Autoimmune Drugs Market Size by Country
10.4.1 Middle East and Africa Autoimmune Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Autoimmune Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Eli Lilly Autoimmune Drugs Products and Services
11.1.5 Eli Lilly Autoimmune Drugs SWOT Analysis
11.1.6 Eli Lilly Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 GSK Autoimmune Drugs Products and Services
11.2.5 GSK Autoimmune Drugs SWOT Analysis
11.2.6 GSK Recent Developments
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 AbbVie Autoimmune Drugs Products and Services
11.3.5 AbbVie Autoimmune Drugs SWOT Analysis
11.3.6 AbbVie Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Autoimmune Drugs Products and Services
11.4.5 Johnson & Johnson Autoimmune Drugs SWOT Analysis
11.4.6 Johnson & Johnson Recent Developments
11.5 Biogen
11.5.1 Biogen Corporation Information
11.5.2 Biogen Overview
11.5.3 Biogen Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Biogen Autoimmune Drugs Products and Services
11.5.5 Biogen Autoimmune Drugs SWOT Analysis
11.5.6 Biogen Recent Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Overview
11.6.3 Amgen Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Amgen Autoimmune Drugs Products and Services
11.6.5 Amgen Autoimmune Drugs SWOT Analysis
11.6.6 Amgen Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Pfizer Autoimmune Drugs Products and Services
11.7.5 Pfizer Autoimmune Drugs SWOT Analysis
11.7.6 Pfizer Recent Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Overview
11.8.3 Roche Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Roche Autoimmune Drugs Products and Services
11.8.5 Roche Autoimmune Drugs SWOT Analysis
11.8.6 Roche Recent Developments
11.9 Baxter
11.9.1 Baxter Corporation Information
11.9.2 Baxter Overview
11.9.3 Baxter Autoimmune Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Baxter Autoimmune Drugs Products and Services
11.9.5 Baxter Autoimmune Drugs SWOT Analysis
11.9.6 Baxter Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Autoimmune Drugs Value Chain Analysis
12.2 Autoimmune Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Autoimmune Drugs Production Mode & Process
12.4 Autoimmune Drugs Sales and Marketing
12.4.1 Autoimmune Drugs Sales Channels
12.4.2 Autoimmune Drugs Distributors
12.5 Autoimmune Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Autoimmune Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Rheumatoid Arthritis (RA)
Table 3. Major Manufacturers of Multiple Sclerosis (MS)
Table 4. Major Manufacturers of Psoriasis
Table 5. Major Manufacturers of Inflammatory Bowel Disease (IBD)
Table 6. Major Manufacturers of Ankylosing Spondylitis (AS)
Table 7. Major Manufacturers of Systemic Lupus Erythematosus (SLE)
Table 8. Global Autoimmune Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Autoimmune Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Autoimmune Drugs Sales by Region (2017-2022) & (K Units)
Table 11. Global Autoimmune Drugs Sales Market Share by Region (2017-2022)
Table 12. Global Autoimmune Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Autoimmune Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Autoimmune Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 15. Global Autoimmune Drugs Sales Market Share Forecast by Region (2023-2028)
Table 16. Global Autoimmune Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 17. Global Autoimmune Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 18. Top Autoimmune Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 19. Autoimmune Drugs Market Trends
Table 20. Autoimmune Drugs Market Drivers
Table 21. Autoimmune Drugs Market Challenges
Table 22. Autoimmune Drugs Market Restraints
Table 23. Global Autoimmune Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 24. Global Autoimmune Drugs Sales Share by Manufacturers (2017-2022)
Table 25. Global Autoimmune Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 26. Ranking of Global Top Autoimmune Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 27. Autoimmune Drugs Revenue Share by Manufacturers (2017-2022)
Table 28. Global Autoimmune Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Drugs as of 2021)
Table 30. Key Manufacturers Autoimmune Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 31. Key Manufacturers Autoimmune Drugs Plants/Factories Distribution
Table 32. Key Manufacturers Autoimmune Drugs Area Served
Table 33. Date of Key Manufacturers Enter into Autoimmune Drugs Market
Table 34. Key Manufacturers Autoimmune Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Autoimmune Drugs Sales (K Units) by Type (2017-2022)
Table 37. Global Autoimmune Drugs Sales Share by Type (2017-2022)
Table 38. Global Autoimmune Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 39. Global Autoimmune Drugs Price (K Units) by Type (2017-2022)
Table 40. Global Autoimmune Drugs Sales (K Units) by Type (2023-2028)
Table 41. Global Autoimmune Drugs Sales Share by Type (2023-2028)
Table 42. Global Autoimmune Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 43. Global Autoimmune Drugs Revenue Share by Type (2023-2028)
Table 44. Global Autoimmune Drugs Price (K Units) by Type (2023-2028)
Table 45. Global Autoimmune Drugs Sales (K Units) by Application (2017-2022)
Table 46. Global Autoimmune Drugs Sales Share by Application (2017-2022)
Table 47. Global Autoimmune Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 48. Global Autoimmune Drugs Price (K Units) by Application (2017-2022)
Table 49. Global Autoimmune Drugs Sales (K Units) by Application (2023-2028)
Table 50. Global Autoimmune Drugs Sales Share by Application (2023-2028)
Table 51. Global Autoimmune Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 52. Global Autoimmune Drugs Revenue Share by Application (2023-2028)
Table 53. Global Autoimmune Drugs Price (K Units) by Application (2023-2028)
Table 54. North America Autoimmune Drugs Sales by Company (2017-2022) & (K Units)
Table 55. North America Autoimmune Drugs Sales Market Share by Company (2017-2022)
Table 56. North America Autoimmune Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 57. North America Autoimmune Drugs Revenue Market Share by Company (2017-2022)
Table 58. North America Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
Table 59. North America Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
Table 60. North America Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. North America Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. North America Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
Table 63. North America Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
Table 64. North America Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. North America Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. North America Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
Table 67. North America Autoimmune Drugs Sales by Country (2023-2028) & (K Units)
Table 68. North America Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. North America Autoimmune Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Europe Autoimmune Drugs Sales by Company (2017-2022) & (K Units)
Table 71. Europe Autoimmune Drugs Sales Market Share by Company (2017-2022)
Table 72. Europe Autoimmune Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 73. Europe Autoimmune Drugs Revenue Market Share by Company (2017-2022)
Table 74. Europe Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
Table 75. Europe Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
Table 76. Europe Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 77. Europe Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 78. Europe Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
Table 79. Europe Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
Table 80. Europe Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 81. Europe Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 82. Europe Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
Table 83. Europe Autoimmune Drugs Sales by Country (2023-2028) & (K Units)
Table 84. Europe Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 85. Europe Autoimmune Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 86. Asia Pacific Autoimmune Drugs Sales by Company (2017-2022) & (K Units)
Table 87. Asia Pacific Autoimmune Drugs Sales Market Share by Company (2017-2022)
Table 88. Asia Pacific Autoimmune Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 89. Asia Pacific Autoimmune Drugs Revenue Market Share by Company (2017-2022)
Table 90. Asia Pacific Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
Table 91. Asia Pacific Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
Table 92. Asia Pacific Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 93. Asia Pacific Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 94. Asia Pacific Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
Table 95. Asia Pacific Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
Table 96. Asia Pacific Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 97. Asia Pacific Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 98. Asia Pacific Autoimmune Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Asia Pacific Autoimmune Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Asia Pacific Autoimmune Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 101. Asia Pacific Autoimmune Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 102. Latin America Autoimmune Drugs Sales by Company (2017-2022) & (K Units)
Table 103. Latin America Autoimmune Drugs Sales Market Share by Company (2017-2022)
Table 104. Latin America Autoimmune Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 105. Latin America Autoimmune Drugs Revenue Market Share by Company (2017-2022)
Table 106. Latin America Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
Table 107. Latin America Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
Table 108. Latin America Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 109. Latin America Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 110. Latin America Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
Table 111. Latin America Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
Table 112. Latin America Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 113. Latin America Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 114. Latin America Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
Table 115. Latin America Autoimmune Drugs Sales by Country (2023-2028) & (K Units)
Table 116. Latin America Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 117. Latin America Autoimmune Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 118. Middle East and Africa Autoimmune Drugs Sales by Company (2017-2022) & (K Units)
Table 119. Middle East and Africa Autoimmune Drugs Sales Market Share by Company (2017-2022)
Table 120. Middle East and Africa Autoimmune Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Autoimmune Drugs Revenue Market Share by Company (2017-2022)
Table 122. Middle East and Africa Autoimmune Drugs Sales by Type (2017-2022) & (K Units)
Table 123. Middle East and Africa Autoimmune Drugs Sales by Type (2023-2028) & (K Units)
Table 124. Middle East and Africa Autoimmune Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Autoimmune Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Autoimmune Drugs Sales by Application (2017-2022) & (K Units)
Table 127. Middle East and Africa Autoimmune Drugs Sales by Application (2023-2028) & (K Units)
Table 128. Middle East and Africa Autoimmune Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Autoimmune Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 130. Middle East and Africa Autoimmune Drugs Sales by Country (2017-2022) & (K Units)
Table 131. Middle East and Africa Autoimmune Drugs Sales by Country (2023-2028) & (K Units)
Table 132. Middle East and Africa Autoimmune Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 133. Middle East and Africa Autoimmune Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 134. Eli Lilly Corporation Information
Table 135. Eli Lilly Description and Overview
Table 136. Eli Lilly Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 137. Eli Lilly Autoimmune Drugs Product and Services
Table 138. Eli Lilly Autoimmune Drugs SWOT Analysis
Table 139. Eli Lilly Recent Developments
Table 140. GSK Corporation Information
Table 141. GSK Description and Overview
Table 142. GSK Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 143. GSK Autoimmune Drugs Product and Services
Table 144. GSK Autoimmune Drugs SWOT Analysis
Table 145. GSK Recent Developments
Table 146. AbbVie Corporation Information
Table 147. AbbVie Description and Overview
Table 148. AbbVie Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 149. AbbVie Autoimmune Drugs Product and Services
Table 150. AbbVie Autoimmune Drugs SWOT Analysis
Table 151. AbbVie Recent Developments
Table 152. Johnson & Johnson Corporation Information
Table 153. Johnson & Johnson Description and Overview
Table 154. Johnson & Johnson Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 155. Johnson & Johnson Autoimmune Drugs Product and Services
Table 156. Johnson & Johnson Autoimmune Drugs SWOT Analysis
Table 157. Johnson & Johnson Recent Developments
Table 158. Biogen Corporation Information
Table 159. Biogen Description and Overview
Table 160. Biogen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 161. Biogen Autoimmune Drugs Product and Services
Table 162. Biogen Autoimmune Drugs SWOT Analysis
Table 163. Biogen Recent Developments
Table 164. Amgen Corporation Information
Table 165. Amgen Description and Overview
Table 166. Amgen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 167. Amgen Autoimmune Drugs Product and Services
Table 168. Amgen Autoimmune Drugs SWOT Analysis
Table 169. Amgen Recent Developments
Table 170. Pfizer Corporation Information
Table 171. Pfizer Description and Overview
Table 172. Pfizer Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 173. Pfizer Autoimmune Drugs Product and Services
Table 174. Pfizer Autoimmune Drugs SWOT Analysis
Table 175. Pfizer Recent Developments
Table 176. Roche Corporation Information
Table 177. Roche Description and Overview
Table 178. Roche Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 179. Roche Autoimmune Drugs Product and Services
Table 180. Roche Autoimmune Drugs SWOT Analysis
Table 181. Roche Recent Developments
Table 182. Baxter Corporation Information
Table 183. Baxter Description and Overview
Table 184. Baxter Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 185. Baxter Autoimmune Drugs Product and Services
Table 186. Baxter Autoimmune Drugs SWOT Analysis
Table 187. Baxter Recent Developments
Table 188. Key Raw Materials Lists
Table 189. Raw Materials Key Suppliers Lists
Table 190. Autoimmune Drugs Distributors List
Table 191. Autoimmune Drugs Customers List
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Autoimmune Drugs Product Picture
Figure 2. Global Autoimmune Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Rheumatoid Arthritis (RA) Product Picture
Figure 4. Multiple Sclerosis (MS) Product Picture
Figure 5. Psoriasis Product Picture
Figure 6. Inflammatory Bowel Disease (IBD) Product Picture
Figure 7. Ankylosing Spondylitis (AS) Product Picture
Figure 8. Systemic Lupus Erythematosus (SLE) Product Picture
Figure 9. Global Autoimmune Drugs Sales Market Share by Application in 2021 & 2028
Figure 10. Hospitals Use Case
Figure 11. Homecare Use Case
Figure 12. Specialty Clinics Use Case
Figure 13. Autoimmune Drugs Report Years Considered
Figure 14. Global Autoimmune Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Autoimmune Drugs Market Size 2017-2028 (US$ Million)
Figure 16. Global Autoimmune Drugs Sales (2017-2022) & (K Units)
Figure 17. Global Autoimmune Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 18. Global Autoimmune Drugs Sales Market Share by Region (2017-2022)
Figure 19. Global Autoimmune Drugs Sales Market Share by Region in 2021
Figure 20. Global Autoimmune Drugs Revenue Market Share by Region in 2017 VS 2021
Figure 21. Global Autoimmune Drugs Sales Share by Manufacturers in 2021
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Autoimmune Drugs Sales in 2021
Figure 23. Autoimmune Drugs Revenue Share by Manufacturers in 2021
Figure 24. Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 25. Global Autoimmune Drugs Revenue Share by Type (2017-2022)
Figure 26. Global Autoimmune Drugs Revenue Growth Rate by Type in 2017 & 2021
Figure 27. Global Autoimmune Drugs Revenue Share by Application (2017-2022)
Figure 28. Global Autoimmune Drugs Revenue Growth Rate by Application in 2017 & 2021
Figure 29. North America Autoimmune Drugs Sales Market Share by Type (2017-2028)
Figure 30. North America Autoimmune Drugs Revenue Market Share by Type (2017-2028)
Figure 31. North America Autoimmune Drugs Sales Market Share by Application (2017-2028)
Figure 32. North America Autoimmune Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Autoimmune Drugs Sales Share by Country (2017-2028)
Figure 34. North America Autoimmune Drugs Revenue Share by Country (2017-2028)
Figure 35. U.S. Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
Figure 36. Canada Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
Figure 37. Europe Autoimmune Drugs Sales Market Share by Type (2017-2028)
Figure 38. Europe Autoimmune Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Europe Autoimmune Drugs Sales Market Share by Application (2017-2028)
Figure 40. Europe Autoimmune Drugs Revenue Market Share by Application (2017-2028)
Figure 41. Europe Autoimmune Drugs Sales Share by Country (2017-2028)
Figure 42. Europe Autoimmune Drugs Revenue Share by Country (2017-2028)
Figure 43. Germany Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. France Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. U.K. Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Italy Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Russia Autoimmune Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Asia Pacific Autoimmune Drugs Sales Market Share by Type (2017-2028)
Figure 49. Asia Pacific Autoimmune Drugs Revenue Market Share by Type (2017-2028)
Figure 50. Asia Pacific Autoimmune Drugs Sales Market Share by Application (2017-2028)
Figure 51. Asia Pacific Autoimmune Drugs Revenue Market Share by Application (2017-2028)
Figure 52. Asia Pacific Autoimmune Drugs Sales

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Systemic Lupus Erythematosus (Sle) Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Systemic Lupus Erythematosus (Sle) Drugs market: According to our latest research, the global Systemic Lupus Erythematosus (Sle) Drugs market looks promising in the next 5 years. As of 2022, the global Systemic Lupus Erythematosus (Sle) Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......

Autoimmune Drugs Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 78

This study focuses on China's Autoimmune Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. Th......

Autoimmune Drugs Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 71

This study focuses on China's Autoimmune Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of......

Autoimmune Drugs Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 201

China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......

Autoimmune Collaboration and Licensing Deals 2016-2023

Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 450

Autoimmune Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the autoimmune deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of autoimmune deals from 2016 to 2023. The report includes coverage of the following autoimmune diseases: Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Infla......

Global Autoimmune Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 29-Aug-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Autoimmune Drugs market: According to our latest research, the global Autoimmune Drugs market looks promising in the next 5 years. As of 2022, the global Autoimmune Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Autoimmune Drugs market......

Global Autoimmune Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 92

Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental ......

Global Systemic Lupus Erythematosus (SLE) Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 75

SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of ......

Global Systemic Lupus Erythematosus (Sle) Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 11-Jul-2023        Price: US 3260 Onwards        Pages: 130

The Systemic Lupus Erythematosus (Sle) Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Systemic Lupus Erythematosus (Sle) Drugs industry, and breaks down according to the type, application, and consumption area of Systemic Lupus Erythematosus (Sle) Drugs. The report also introduces players in the industry from the per......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs